The dopamine system in idiopathic generalized epilepsies: Identification of syndrome-related changes

The present study tests the hypothesis that the dopamine system is altered in idiopathic generalized epilepsy (IGE), and that the pattern of possible changes differs between juvenile myoclonic epilepsy (JME) and epilepsy with tonic-clonic seizures only (GTCS). The dopamine (DA) system was investigated with PET and a DA transporter (DAT) ligand [(11)C]PE2I in 13 patients with JME, 13 with GTCS, and 12 healthy controls. The binding potential (BP) to DAT was quantified in the caudate, putamen, and midbrain. The possible impact on function was evaluated by correlating regional BP with test performance in a battery of neuropsychological tests. Both patient groups showed a reduced BP compared to controls, albeit in different locations. JME patients had a lower tracer binding than controls in the midbrain (0.8+/-0.1 vs. 1.0+/-0.2, p=0.019), whereas GTCS patients had reduced tracer binding in the putamen (5.9+/-1.6 vs. 7.1+/-1.2, p=0.023). While GTCS patients showed impaired performance in motor functions and on one test of executive function, JME patients performed poorly also in tests of working memory and several tests of executive function. Alterations in the DA system seem to exist in both GTCS and JME. However, the regional distribution of these changes differs between the two syndromes, as does their association with psychomotor and working memory performance. The present data suggest that the two forms of IGE have different neuronal substrates.

[1]  D. Janz,et al.  Epilepsy with impulsive petit mal (Juvenile Myoclonic Epilepsy) , 1985, Acta neurologica Scandinavica.

[2]  C. Halldin,et al.  Reduced dopamine transporter binding in patients with juvenile myoclonic epilepsy , 2008, Neurology.

[3]  I. Scheffer,et al.  Reduced striatal D1 receptor binding in autosomal dominant nocturnal frontal lobe epilepsy , 2008, Neurology.

[4]  V. M. Pickel,et al.  Immunogold Localization of the Dopamine Transporter: An Ultrastructural Study of the Rat Ventral Tegmental Area , 1997, The Journal of Neuroscience.

[5]  Christer Halldin,et al.  Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: Association between striatal dopamine markers and motor hyperactivity , 2005, Biological Psychiatry.

[6]  Raffaele Canger,et al.  Frontal cognitive dysfunction in juvenile myoclonic epilepsy , 2008, Epilepsia.

[7]  A. Laurent,et al.  Laparoscopy as a routine approach for left lateral sectionectomy , 2007, The British journal of surgery.

[8]  Erwan Dupont,et al.  In vivo imaging of dopamine receptors in a model of temporal lobe epilepsy , 2010, Epilepsia.

[9]  L. Bäckman,et al.  The role of the striatal dopamine transporter in cognitive aging , 2005, Psychiatry Research: Neuroimaging.

[10]  A. Rominger,et al.  PET and SPECT in epilepsy: A critical review , 2009, Epilepsy & Behavior.

[11]  H Gastaut,et al.  Clinical and Electroencephalographical Classification of Epileptic Seizures , 1970, Epilepsia.

[12]  T. Hökfelt,et al.  Classical transmitters in the CNS , 1984 .

[13]  S. Izenwasser,et al.  Dopamine transporters : chemistry, biology, and pharmacology , 2008 .

[14]  D. Janz,et al.  The Idiopathic Generalized Epilepsies of Adolescence with Childhood and Juvenile Age of Onset , 1997, Epilepsia.

[15]  C. Deransart,et al.  The control of seizures by the basal ganglia? A review of experimental data. , 2002, Epileptic disorders : international epilepsy journal with videotape.

[16]  M. Laruelle,et al.  In Vivo Imaging of Dopamine Receptors , 2010 .

[17]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[18]  B E Swartz,et al.  Visual working memory in primary generalized epilepsy , 1996, Neurology.

[19]  Maryse Lassonde,et al.  Idiopathic epileptic syndromes and cognition , 2006, Neuroscience & Biobehavioral Reviews.

[20]  E. Halgren,et al.  Studies of working memory using 18FDG-positron emission tomography in normal controls and subjects with epilepsy. , 1996, Life sciences.

[21]  R. Mattson,et al.  Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. , 1989, Epilepsia.

[22]  Yuan-Hwa Chou,et al.  [(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain. , 2003, European journal of nuclear medicine and molecular imaging.

[23]  D C Reutens,et al.  Idiopathic generalized epilepsy of adolescence , 1995, Neurology.

[24]  Christer Halldin,et al.  Quantitative analyses of regional [11C]PE2I binding to the dopamine transporter in the human brain: a PET study , 2006, European Journal of Nuclear Medicine and Molecular Imaging.

[25]  L L Bailet,et al.  The Impact of Childhood Epilepsy on Neurocognitive and Behavioral Performance: A Prospective Longitudinal Study , 2000, Epilepsia.

[26]  S. Amara,et al.  Dynamic regulation of the dopamine transporter. , 2003, European journal of pharmacology.

[27]  C. Greer,et al.  Mediation of myoclonic seizures by dopamine and clonic seizures by acetylcholine and GABA. , 1977, Life sciences.

[28]  Markus Piel,et al.  Decreased Dopamine D2/D3‐Receptor Binding in Temporal Lobe Epilepsy: An [18F]Fallypride PET Study , 2006, Epilepsia.

[29]  M J Koepp,et al.  Juvenile myoclonic epilepsy – a generalized epilepsy syndrome? , 2005, Acta neurologica Scandinavica. Supplementum.

[30]  S. Duncan,et al.  Neuropsychological profiles of patients with juvenile myoclonic epilepsy and their siblings: A preliminary controlled experimental video-EEG case series , 2009, Epilepsy & Behavior.

[31]  C. Deransart,et al.  The role of basal ganglia in the control of generalized absence seizures , 1998, Epilepsy Research.

[32]  D. Janz,et al.  Neuropathological Findings in Primary Generalized Epilepsy: A Study of Eight Cases , 1984, Epilepsia.

[33]  Li Min Li,et al.  Voxel-based morphometry in patients with idiopathic generalized epilepsies , 2006, NeuroImage.

[34]  A. Biraben,et al.  Involvement of the basal ganglia in refractory epilepsy: an 18F-fluoro-L-DOPA PET study using 2 methods of analysis. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[35]  Paul J. Laurienti,et al.  An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets , 2003, NeuroImage.

[36]  Sabine Rona,et al.  Chronic High‐Frequency Deep Brain Stimulation of the STN/SNr for Progressive Myoclonic Epilepsy , 2007, Epilepsia.

[37]  John S Duncan,et al.  Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy , 2003, Neurology.

[38]  M. Sheehan,et al.  Presynaptic regulation of electrically evoked dopamine overflow in nucleus accumbens: a pharmacological study using fast cyclic voltammetry in vitro , 1991, Naunyn-Schmiedeberg's Archives of Pharmacology.

[39]  K. Gale,et al.  Subcortical structures and pathways involved in convulsive seizure generation. , 1992, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[40]  P. Garris,et al.  Efflux of dopamine from the synaptic cleft in the nucleus accumbens of the rat brain , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  O. Devinsky,et al.  Frontal functions in juvenile myoclonic epilepsy. , 1997, Neuropsychiatry, neuropsychology, and behavioral neurology.

[42]  C Crouzel,et al.  Carbon-11 epidepride: a suitable radioligand for PET investigation of striatal and extrastriatal dopamine D2 receptors. , 1999, Nuclear medicine and biology.

[43]  T. Robbins,et al.  Striatal contributions to working memory: a functional magnetic resonance imaging study in humans , 2004, The European journal of neuroscience.

[44]  Suresh Gurbani,et al.  Childhood absence epilepsy: Behavioral, cognitive, and linguistic comorbidities , 2008, Epilepsia.

[45]  I Savic,et al.  MRS shows syndrome differentiated metabolite changes in human-generalized epilepsies , 2004, NeuroImage.

[46]  M. Caron,et al.  Molecular characterization of the dopamine transporter. , 1993, Trends in pharmacological sciences.

[47]  B. Yamamoto,et al.  Dopaminergic and GABAergic modulation of glutamate release from rat subthalamic nucleus efferents to the substantia nigra , 2006, Brain Research.

[48]  Bruce Hermann,et al.  Thalamofrontal circuitry and executive dysfunction in recent‐onset juvenile myoclonic epilepsy , 2009, Epilepsia.

[49]  R. C. Oldfield.  The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.

[50]  Timothy A. Pedley,et al.  Epilepsy : a comprehensive textbook , 2008 .

[51]  E. Halgren,et al.  Primary or working memory in frontal lobe epilepsy , 1996, Neurology.

[52]  S. Hong,et al.  CBF changes in drug naive juvenile myoclonic epilepsy patients , 2007, Journal of Neurology.

[53]  A. Sakamoto,et al.  Magnetic resonance spectroscopy reveals an epileptic network in juvenile myoclonic epilepsy , 2009, Epilepsia.

[54]  M. Szente,et al.  Stimulation of substantia nigra pars reticulata suppresses neocortical seizures , 1992, Brain Research.

[55]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[56]  I Savic,et al.  MR Spectroscopy Shows Reduced Frontal Lobe Concentrations of N‐Acetyl Aspartate in Patients with Juvenile Myoclonic Epilepsy , 2000, Epilepsia.

[57]  Ivanka Savic,et al.  Structural changes in patients with primary generalized tonic and clonic seizures , 2006, Neurology.

[58]  A. Watanabe.  Dopamine research advances , 2008 .

[59]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[60]  F. Woermann,et al.  Abnormal cerebral structure in juvenile myoclonic epilepsy demonstrated with voxel-based analysis of MRI. , 1999, Brain : a journal of neurology.

[61]  E. Borrelli,et al.  Neuroprotective Role of Dopamine Against Hippocampal Cell Death , 2000, The Journal of Neuroscience.

[62]  S. Zuberi,et al.  Memory consolidation and accelerated forgetting in children with idiopathic generalized epilepsy , 2007, Epilepsy & Behavior.

[63]  Kátia Lin,et al.  Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate , 2006, Epilepsy & Behavior.

[64]  Kátia Lin,et al.  Neuropsychological profile of patients with juvenile myoclonic epilepsy: A controlled study of 50 patients , 2007, Epilepsy & Behavior.

[65]  Massimo Avoli,et al.  Generalized Epilepsy: Neurobiological Approaches , 1990 .

[66]  P. Voorn,et al.  Development of Dopamine - Containing Systems in the CNS , 1992 .

[67]  M. Starr,et al.  Effects of dopamine D3 receptor agonists on pilocarpine-induced limbic seizures in the rat , 1994, Neuroscience.

[68]  L. Gjerstad,et al.  Predictors of Neuropsychological Impairment in Seizure‐free Epilepsy Patients , 2006, Epilepsia.

[69]  M. Bannon,et al.  Valproate robustly increases Sp transcription factor‐mediated expression of the dopamine transporter gene within dopamine cells , 2007, The European journal of neuroscience.

[70]  S. Moshé,et al.  Substantia Nigra-Mediated Control of Generalized Seizures , 1990 .

[71]  A. Lammertsma,et al.  Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.

[72]  Jerome Engel,et al.  A Proposed Diagnostic Scheme for People with Epileptic Seizures and with Epilepsy: Report of the ILAE Task Force on Classification and Terminology , 2001, Epilepsia.

[73]  F Andermann,et al.  Idiopathic Generalized Epilepsy with Generalized and Other Seizures in Adolescence , 2001, Epilepsia.

[74]  S. Charpier,et al.  Functional organization of the circuits connecting the cerebral cortex and the basal ganglia: implications for the role of the basal ganglia in epilepsy. , 2002, Epileptic disorders : international epilepsy journal with videotape.

[75]  G. Douaud,et al.  PET evidence for a role of the basal ganglia in patients with ring chromosome 20 epilepsy , 2004, Neurology.

[76]  A. Nieoullon.  Dopamine and the regulation of cognition and attention , 2002, Progress in Neurobiology.

[77]  E. Trinka,et al.  Idiopathic generalized epilepsies with pure grand mal: clinical data and genetics , 2001, Epilepsy Research.

[78]  K. Någren,et al.  Substantial Thalamostriatal Dopaminergic Defect in Unverricht‐Lundborg Disease , 2007, Epilepsia.

[79]  Pierre Jallon,et al.  Subcortical Nuclei Volumetry in Idiopathic Generalized Epilepsy , 2005, Epilepsia.

[80]  W. Turski,et al.  Dopamine-sensitive anticonvulsant site in the rat striatum , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[81]  Sun I. Kim,et al.  Regional grey matter abnormalities in juvenile myoclonic epilepsy: A voxel-based morphometry study , 2007, NeuroImage.

[82]  C. Halldin,et al.  Regional reductions in serotonin 1A receptor binding in juvenile myoclonic epilepsy. , 2005, Archives of neurology.

[83]  K. Zilles,et al.  Human brain atlas: For high‐resolution functional and anatomical mapping , 1994, Human brain mapping.

[84]  P. Nathan,et al.  Molecular Imaging of the Dopaminergic System and its Association with Human Cognitive Function , 2006, Biological Psychiatry.

[85]  A. Biraben,et al.  Basal ganglia involvement in temporal lobe epilepsy , 2008, Neurology.

[86]  E. Borrelli,et al.  Dopamine in neurotoxicity and neuroprotection: what do D2 receptors have to do with it? , 2006, Trends in Neurosciences.